Aptar and Sonmol develop digital platform for respiratory-related therapies

Collaboration includes strategic investment by Aptar Pharma

0
63
Aptar
Photo - Aptar

AptarGroup, a global leader in consumer dispensing, active packaging and drug delivery solutions and services, and Sonmol, a leading Chinese digital respiratory therapeutics company, have announced a collaboration for developing a digital therapies and services platform targeting respiratory and other diseases. This collaboration will initially focus on bringing together connected…

Choose your subscription to read more

Trial

0 /mo
Not sure which package to choose? Try full access
  • ₹ 0 for 4 weeks*

PSA Plan 1

1000 /year
Access to the website, weekly eMail newsletter
  • ₹1,000.00 for 1 year*

PSA Plan 2

1500 /Year
Access to the website, weekly eMail newsletter and monthly eMag
  • ₹1500 for Year*

PSA Plan 3

2000 /Year
Print Copy, access to the website, weekly eMail newsletter and monthly eMag
  • ₹2,000.00 for 1 year*